Aseptic fill and finish: the container, the line and the media fill, in that order

Scoping the operation

1. Choose the container closure system first. Vial, prefilled syringe or cartridge decides the line, the stoppering, the inspection and much of the stability work. Changing it later is effectively restarting. Decide it from the route of administration and the intended user, not from what the site already runs.
2. Establish the product's tolerances before the line is selected. Shear sensitivity, silicone oil interaction, tungsten residue from syringe manufacture and surface adsorption all attack biologics in ways that only appear in the final container. Small scale studies on these cost weeks; discovering them at engineering batch costs months.
3. Ask for the site's media fill history, not its capability statement. Three consecutive successful media fills at the scale and line you would use, with the interventions represented, and an acceptance criterion of no contaminated units. Ask what interventions were simulated, because a media fill without the hard interventions proves little.
4. Read the environmental monitoring data. Grade A monitoring results over a period, with excursion investigations and how they were closed, tell you more about a facility than any tour. A site unwilling to share trended data under confidentiality is telling you something.
5. Fix container closure integrity testing early. Deterministic methods such as helium leak or high voltage leak detection have largely replaced the dye ingress test, and the method has to be developed for your specific container. This is routinely left until stability is already running.

Technology transfer and the engineering batch

Transfer is a documentation exercise and a scale exercise at once. Hold times, filter compatibility and extractables, mixing at the new vessel geometry and line speed all have to be re-established, and the engineering batch is where they are found.

Budget for at least one engineering batch that produces nothing saleable. Programmes that plan straight into a clinical batch tend to produce an investigation instead.

Inspection and what counts as a defect

Every unit is inspected, manually or automatically, and the defect library has to be agreed and the inspectors qualified against it. For a protein product, particles are where the argument happens, because the product itself can form them.

Agree the accept and reject criteria before the first batch, with images. A defect library written after a batch has been inspected is a negotiation rather than a specification.

Scheduling reality

Sterile lines are booked far ahead and a slot missed is usually a quarter lost. Confirm the slot, the campaign length and what happens if your material is late, because the penalty terms tell you how real the slot is.

Secondary packaging, labelling for the destination markets and release testing sit after the fill and routinely add weeks nobody planned for. Map them onto the timeline before committing to a clinical start date.

aseptic liquid filling, and the steps around the filler

Filling a sterile liquid is a chain in which the filler is one link. The product is sterile filtered into a holding vessel, containers and closures are washed and depyrogenated or arrive ready to use, the filling happens inside grade A air within an isolator or barrier system, stoppering follows immediately and capping after, and every intervention is documented. Around it sit media fills to qualify the process, continuous viable and non-viable monitoring, and container closure integrity testing. Fill weight accuracy is the easy part; the environment is what the quote is really for.

A bag filling system and the aseptic path through it

A bag filling system fills a pre-sterilised single use bag through a closed path, so the specification is the tubing set, the connector type, the filling accuracy by weight and whether the fill occurs inside an isolator or a closed assembly. Gravimetric control beats volumetric for viscous product. Batch records come from the controller, so its data integrity features are part of the qualification.

A bottle filling system and the format it is qualified for

A bottle filling system is qualified for a container closure combination rather than for a liquid, so the bottle, the cap and the torque are as much part of the validation as the pump. Fill accuracy, residual volume and the cleaning or single use path are the comparison points. Where the product is sterile, the filling zone's air classification and its monitoring plan are what the regulator reads first.

Isolator technology and the alternative to a cleanroom

Isolator technology encloses the critical zone so the operator never shares air with the product, which is why it now carries most new aseptic filling rather than an open restricted access barrier. Decontamination is by vaporised hydrogen peroxide with a proven cycle, and glove integrity testing is the recurring operational burden. The trade is capital and cycle time against a far smaller monitored environment.

Viral inactivation bioprocess steps and the two orthogonal ones

A viral inactivation bioprocess needs two steps that work by different mechanisms, typically low pH hold and a nanofiltration step, because clearance is claimed as the sum of orthogonal contributions. Each is validated by spiking studies with model viruses at small scale. Hold time, temperature and pH tolerance windows are what the process description has to state, since the claim rests on staying inside them.

Bioprocess tubing and the property that is specified

Bioprocess tubing is specified by its material, its pump life in a peristaltic head, its extractables profile and whether it can be welded or sealed, not by its bore alone. Silicone pumps well and is gas permeable; thermoplastic elastomers are weldable and hold a sterile boundary. The whole assembly's gamma dose rating and its supplier documentation are what make it usable in a regulated step.

A single use pressure sensor and the reading it protects

A single use pressure sensor is built into a disposable flow path and read without contacting the fluid, which is what allows filtration and chromatography steps to be monitored in a closed system. Accuracy drift over the run and the zeroing procedure are the specifications to compare. Because the sensor is consumable, its cost per batch enters the same calculation the bag and the tubing do.

Common questions

What does aseptic fill and finish cover?

Formulation of the final drug product, sterile filtration, filling into the primary container, stoppering and sealing, inspection, and labelling and packaging. It is the step where the product becomes the thing a patient receives.

How do I choose a fill finish cdmo?

On the container formats it runs routinely, its media fill and environmental monitoring record, its inspection capability, and slot availability. Capacity in eighteen months is not capacity, and the format it runs occasionally is the one that will cause problems.

What changes with syringe filling machines?

Prefilled syringes bring silicone lubrication, the plunger and the needle shield into the product contact picture, plus functional testing of break-loose and glide force. It is a materially larger validation exercise than vials.

What is the acceptance criterion for a media fill?

No contaminated units, with any positive triggering a full investigation. Three consecutive successful runs are the conventional qualification, with periodic requalification and any significant change requiring repetition.

Browse by service class

• Compare Gene synthesis on advertised prices